Story thread · 2 reports / 1 sources
Immunology Drugmaker Electra Raises $350 Million in Upsized IPO
bloomberg.com · 17h · first report
Electra Therapeutics Inc., a clinical-stage developer of immunology drugs, raised $350 million in an upsized US initial public offering priced at the mid-point of its marketed range.
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.